FDA Inspection
Mid South Biologics, LLCMid South Biologics, LLC – FDA Inspection, Feb 16, 2018
Record Details
This FDA Inspection record concerns Mid South Biologics, LLC, with an inspection on February 16, 2018, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 8018c4f3-9ec7-47e0-9b8e-be1b4c2f685e
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1041217
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 1271.180(a)Procedures to meet core CTGP
- 21 CFR 1271.270(a)Records maintained concurrently
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Mid South Biologics, LLC
3| Date | Classification | Office | Project area |
|---|---|---|---|
| June 17, 2016 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| June 26, 2014 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| May 2, 2011 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Mid South Biologics, LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.